Effects of citalopram on the excitability of the human motor cortex: A paired magnetic stimulation study

Journal of the Neurological Sciences

Volumn 221, Issue 1-2, 2004, Pages 41-46

  Robol, Elisa ^a   Fiaschi, Antonio ^a   Manganotti, Paolo ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Citalopram; Drug; Motor excitability; Plasticity; Transcranial magnetic stimulation

Indexed keywords

CITALOPRAM;

ADULT; AMPLITUDE MODULATION; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DRUG EFFECT; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; LATENT PERIOD; MAGNETIC STIMULATION; MALE; MOTOR CORTEX; NERVE CONDUCTION; NORMAL HUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; CITALOPRAM; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MAGNETICS; MALE; MOTOR ACTIVITY; MOTOR CORTEX; SENSITIVITY AND SPECIFICITY; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 2642515518     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.03.007     Document Type: Article

References (56)

1. Ziemann U., Muellbacher W., Hallett M., Cohen L.G. Modulation of practice-dependent plasticity in human motor cortex. Brain. 124:2001;1171-1181
2. Butefisch C.M., Davis B.C., Sawaki L., Waldvogel D., Classen J., Koplylev L., et al. Modulation of use-dependent plasticity by D-amphetamine. Ann. Neurol. 51:2000;59-68
3. Johansson B.B. Brain plasticity and stroke rehabilitation. The Willis lecture. Stroke. 31:2003;223-230
4. Nudo R.J., Plautz E.J., Frost S.B. Role of adaptive plasticity in recovery of function after damage to motor cortex. Muscle Nerve. 24:2001;1000-1019
5. Jansen K.L., Faull R.L., Dragunow M., Leslie R.A. Distribution of excitatory and inhibitory amino acid, sigma, monoamine, catecholamine, acetylcholine, opioid, neurotensin, substance P, adenosine and neuropeptide Y receptors in human motor and somatosensory cortex. Brain Res. 566:1991;225-238
6. Gu Q., Singer W. Involvement of serotonin in developmental plasticity of kitten visual cortex. Eur. J. Neurosci. 7:1995;1146-1153
7. Hasselmo M.E. Neuromodulation and cortical function: modelling the physiological basis of behavior. Behav. Brain Res. 67:1995;1-27
8. Aghajanian G.K., Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology. 36:1977;589-599
9. Nedergaard S., Engberg I., Flatman J.A. The modulation of excitatory amino acid responses by serotonin in the cat neocortex in vitro. Cell Mol. Neurobiol. 7:1987;367-379
10. Reynolds J.N., Baskys A., Carlen P.L. The effects of serotonin on N-methyl-D-aspartate and synaptically evoked depolarizations in rat neocortical neurons. Brain Res. 456:1988;286-292
11. Feng J., Cai X., Zhao J., Yan Z. Serotonin receptors modulate GABA (A) receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons. J. Neurosci. 21:2001;6502-6511
12. Roerig B., Katz L.C. Modulation of intrinsic circuits by serotonin 5-HT3 receptors in developing ferret visual cortex. J. Neurosci. 17:1997;8324-8338
13. Plewnia C., Hoppe J., Hiemke C., Bartels M., Cohen L.G., Gerloff C. Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine. Neurosci. Lett. 27, 330(3):2002;231-234
14. Ilic T.V., Korchounov A., Ziemann U. Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline. Neurosci. Lett. 319:2002;116-120
15. Werhahn K.J., Forderreutther S., Straube A. Effects of the serotonin 1B/1D receptor agonist zolmitriptan on motor cortical excitability in humans. Neurology. 51:1998;896-898
16. Manganotti P., Bortolomasi M., Zanette G., Pawelzik T., Giacopuzzi M., Fiaschi A. Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation. J. Nerol. Sci. 15, 184(1):2001;27-32
17. Werhahn K.J., Kunesch E., Noachtar S., Benecke R., Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J. Physiol. 517:1999;591-597
18. Rizzo V., Quartarone A., Bagnato S., Battaglia F., Majorana G., Ghirlanda P. Modification of cortical excitability induced by gabapentin: a study by transcranial magnetic stimulation. Neurol. Sci. 22(3):2001;229-232
19. Liepert J., Schardt S., Weiller C. Orally administered atropine enhances motor cortex excitability: a transcranial magnetic stimulation study in human subjects. Neurosci. Lett. 300:2001;149-152
20. Manganotti P., Bongiovanni L.G., Zanette G., Fiaschi A. Cortical excitability in patients after loading doses of lamotrigine: a brain magnetic stimulation study. Epilepsia. 40:1999;316-321
21. Ziemann U., Lonnecker S., Steinhoff B.J., Paulus W. The effects of lorazepam on the motor cortical excitability in man. Exp. Brain Res. 109:1996;127-135
22. Reis J., Tergau F., Hamer H.M., Muller H.H., Knake S., Fritsch B., et al. Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia. 43:2002;1149-1156
23. Liepert J., Schwenkreis P., Tegenthoff M., Malin J.P. The glutamate antagonist Riluzole suppresses intracortical facilitation. J. Neural Transm. 104:1997;1207-1214
24. Ziemann U., Bruns D., Paulus W. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation. Neurosci. Lett. 208:1996;187-190
25. Siebner H.R., Rothwell J. Transcranial magnetic stimulation: new insights into representational cortical plasticity. Exp. Brain Res. 148:2003;1-16
26. Ziemann U., Rothwell J.C., Ridding M.C. Interaction between intracortical inhibition and facilitation in human motor cortex. J. Physiol. 496:1996;873-881
27. Bezchlibnyk-Bulter K., Alekcic I., Kennedy S.H. Citalopram - a review of pharmacological and clinical effects. J. Psychiatry Neurosci. 25(3):2000;241-254
28. Milne R.J., Goa K.L. A review of its pharmacodynamic and pharmacocinetic properties, and therapeutic potential in depressive illness. Drugs. 41(3):1991;450-477
29. Pollock B.G. Citalopram: a comprehensive review. Expert Opin. Pharmacother. 2(4):2001;681-698
30. Brasil Neto J.P., Cohen L.G., Panizza M., Nillsen J., Roth B.J., Hallett M. Optimal focal transcranial magnetic activation of the human motor cortex: effects of coil orientation, shape of the induced current pulse, and stimulus intensity. J. Clin. Neurophysiol. 9:1992;132-136
31. Rossini P.M., Barker A.T., Berardelli A., Caramia M.D., Caruso G., Cracco R.Q., et al. Non invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of IFCN commitee. Electroencephalogr. Clin. Neurophysiol. 91:1994;79-92
32. Inghilleri M., Berardelli A., Marchetti P., Manfredi M. Effects of diazepam, baclofen, and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp. Brain Res. 109:1996;467-472
33. Kujirai T., Caramia M.D., Rothwell J.C., Day B., Thompson P.D., Ferbert A., et al. Cortico-cortical inhibition in human motor cortex. J. Physiol. (Lond.). 471:1993;501-519
34. Ziemann U., Lonnecker S., Steinhoff B.J., Paulus W. Inhibition of human motor cortex by ethanol: a transcranial magnetic stimulation study. Brain. 118:1995;1437-1446
35. Manganotti P., Zanette G., Bonato C., Tinazzi M., Polo A., Fiaschi A. Crossed and direct effects of digital nerve stimulation on motor evoked potential: a study with magnetic stimulation. Electroencephalogr. Clin. Neurophysiol. 105:1997;280-289
36. Walker-Batson D., Smith P., Curtis S., Unwin H., Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Stroke. 26:1995;2254-2259
37. Goldstein L.B. Basic and clinical studies on pharmacological effects on recovery from brain injury. J. Neurol. Transplant. Plast. 4:1993;175-192
38. Goldstein L.B. Potential effects of common drugs on stroke recovery. Arch. Neurol. 55:1998;454-456
39. Feeney D.M. Mechanisms of noradrenergic modulation of physical therapy: effects on functional recovery after cortical injury. Goldstein L.B. Restorative neurology: advances in pharmacotherapy for recovery after stroke. 1998;35-78 Futura Publishing, Armonk, NY
40. Saponjic R.M., Hoane M.R., Barth T.M. Acetylcoline and recovery of function following brain injury. Goldstein L.B. Restorative neurology: advances in pharmacotherapy for recovery after stroke. 1998;79-89 Futura Publishing, Armonk, NY
41. Schallert T., Hernandez T.D. GABAergic drugs and neuroplasticity after brain injury: impact on functional recovery. Goldstein L.B. Restorative Neurology: advances in pharmacotherapy for recovery after stroke. 1998;91-120 Futura Publishing, Armonk, NY
42. Barth T.M., Hoane M.R., Barbay S. Effect of glutamate antagonists on the recovery and maintenance of behavioral functions after brain injury. Goldstein L.B. Restorative Neurology. Advances in pharmacotherapy for recovery after stroke. 1998;91-120 Futura Publishing, Armonk, NY
43. Feeney D.M., Sutton R.L. Pharmacotherapy for recovery of function after brain injury. Crit. Rev. Neurobiol. 3:1987;135-197
44. Corwin J.V., Kanter S., Watson R.T., Heilman K.M., Valenstein E., Hashimoto A. Apomorphine has a therapeutic effect on neglect produced by unilateral dorsomedial prefrontal cortex lesions in rats. Exp. Neurol. 94:1986;683-689
45. Dam M., Tonin P., De Boni A., Pizzolato G., Casson S., Ermani M., et al. Effects of Fluoxetine and Maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke. 27:1996;1211-1214
46. Ziemann U., Lonnecker S., Steinhoff B.J., Paulus W. Effects of antiepiletic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann. Neurol. 40:1996;367-378
47. Ziemann U., Tergau F., Bruns D., Baudewig J., Paulus W. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr. Clin. Neurophysiol. 105:1997;430-437
48. McCormick D.A. GABA as inhibitory neurotransmitter in human cerebral cortex. J. Neurophysiol. 62:1989;1018-1027
49. Priori A., Berardelli A., Inghilleri M., Accornero N., Manfredi M. Motor cortical inhibition and dopaminergic system. Brain. 117:1994;317-323
50. Triggs W.J., Macdonnel R.A., Cros D., Chiappa K.H., Shahani B.T., Day B.J. Motor inhibition and excitation are independent effects of magnetic stimulation. Ann. Neurol. 32:1992;345-351
51. Chen R., Samii A., Canos M., Wassermann E.M., Hallet M. Effects of phenytoin on cortical excitability in humans. Neurology. 49:1997;881-883
52. Baldessarini R.J. Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors. Psychopharmacol. Bull. 20:1984;224-239
53. Baldessarini R.J. Current status of antidepressants: clinical pharmacology and therapy. J. Clin. Psychiatry. 50:1989;117-126
54. Fhur P., Agostino R., Hallett M. Spinal motor neuron excitability during silent period after cortical stimulation. Electroencephalogr. Clin. Neurophysiol. 81:1991;257-262
55. Wilson S.A., Lockwood R.J., Thickbroom G.W., Mastaglia F.L. The muscle silent period following transcranial magnetic stimulation. J. Neurol. Sci. 114:1993;216-222
56. Cantello R., Giannelli M., Civardi C., Mutani R. Magnetic stimulation: the silent period after motor evoked potential. Neurology. 42:1992;1951-1959